DrugsControl Media Services

News Detail

Gilead questions WHO study that cast doubts on drug's Covid-19 benefits (16-10-2020)

Washington, 16 Oct 2020: Gilead Sciences Inc has questioned the findings of a World Health Organization (WHO) study that concluded its Covid-19 drug remdesivir does not help patients who have been admitted to hospital.


The American company told Reuters the ......
View Details

Source : Hindustan Times

Related News